tirzepatide comparison vs. Semaglutide for Weight Loss Tirzepatide and Semaglutide key differences,

Injectable semaglutide (Ozempic, Wegovy) has no specific meal timing requirements

Women are not intended to use Cialis, and there are minimal studies to explore the potential outcomes, so its best for people assigned female at birth to not take this medication

Intended for adults with a BMI of 30 or greater, or 27 or greater with a weight-related health issue, Wegovy is proven to help patients lose an average of 15% of their body weight over 68 weeks

So where does that leave us

Head-to-head comparison on key outcomes On weight loss, tirzepatide has consistently outperformed semaglutide

Sperm production often drops dramatically within three to six months of starting TRT and may not fully recover after stopping it, especially with long-term use